• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9q22.3 肿瘤抑制基因失活预测头颈部鳞状细胞癌患者的预后。

Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma.

机构信息

Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India.

出版信息

Anticancer Res. 2013 Mar;33(3):1215-20.

PMID:23482805
Abstract

AIM

This study examined the prognostic significance of candidate tumor suppressor genes (TSGs) PHD finger protein-2 (PHF2), Fanconi anaemia complementation group C (FANCC) and human homologue of Drosophila patched gene (PTCH1), in head and neck squamous cell carcinoma (HNSCC) treated primarily with surgery, or surgery followed by adjuvant radiotherapy.

PATIENTS AND METHODS

Eighty-four patients with HNSCC were followed-up for recurrence/death for up to five years after diagnosis. Molecular alterations (deletion/methylation) of TSGs and human papilloma virus (HPV) status were determined in previous studies of our group. Statistical analyses of correlation of genetic alterations with treatment response and survival were carried out.

RESULTS

Alterations of FANCC and PTCH1 were significantly associated with locoregional recurrence/death. In the surgery with adjuvant radiotherapy-group (n=56), patients showing alterations in FANCC and in PTCH1 were seven- and six-times, respectively, more likely to have locoregional recurrence compared to those with no alterations. In addition, the presence of alterations of both FANCC and PTCH1 had remarkable prognostic significance.

CONCLUSION

FANCC and PTCH1 alterations might be used as molecular markers for prognosis and to develop strategies for effective treatment planning.

摘要

目的

本研究旨在探讨候选抑癌基因(TSGs)PHD 指状蛋白-2(PHF2)、范可尼贫血互补群 C(FANCC)和果蝇 patched 基因(PTCH1)的人类同源物在头颈部鳞状细胞癌(HNSCC)患者中的预后意义,这些患者主要接受手术治疗或手术加辅助放疗。

患者和方法

84 例 HNSCC 患者在诊断后最多随访 5 年以记录复发/死亡情况。本研究组之前的研究中确定了 TSGs 的分子改变(缺失/甲基化)和人乳头瘤病毒(HPV)状态。对遗传改变与治疗反应和生存的相关性进行了统计分析。

结果

FANCC 和 PTCH1 的改变与局部区域复发/死亡显著相关。在接受手术加辅助放疗的 56 例患者中,与无改变的患者相比,FANCC 和 PTCH1 改变的患者局部区域复发的可能性分别增加了 7 倍和 6 倍。此外,FANCC 和 PTCH1 改变的存在具有显著的预后意义。

结论

FANCC 和 PTCH1 的改变可以作为预测分子标志物,以制定有效的治疗计划策略。

相似文献

1
Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma.9q22.3 肿瘤抑制基因失活预测头颈部鳞状细胞癌患者的预后。
Anticancer Res. 2013 Mar;33(3):1215-20.
2
Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.FANCC 和 PTCH1 与头颈部早期发育不良病变的发展有关。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S528-38. doi: 10.1245/s10434-011-1991-x. Epub 2011 Aug 23.
3
Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.染色体9q22.3区域候选基因PHF2、FANCC、PTCH1和XPA的改变:在早发性和晚发性乳腺癌中的病理意义
Mol Cancer. 2008 Nov 6;7:84. doi: 10.1186/1476-4598-7-84.
4
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.对头颈鳞状细胞癌进行全面基因组分析,揭示 FGFR1 扩增和肿瘤基因组改变负担可作为生存预后的生物标志物。
Eur J Cancer. 2018 Mar;91:47-55. doi: 10.1016/j.ejca.2017.12.016. Epub 2018 Jan 11.
5
PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.PITX2和PANCR基因的DNA甲基化可预测头颈部鳞状细胞癌患者的总生存期。
Oncotarget. 2016 Nov 15;7(46):75827-75838. doi: 10.18632/oncotarget.12417.
6
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.NDN和CD1A是头颈部鳞状细胞癌患者新的预后甲基化标志物。
BMC Cancer. 2015 Oct 30;15:825. doi: 10.1186/s12885-015-1806-8.
7
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.头颈部鳞状细胞癌(HNSCC)中范可尼贫血互补组A(FancA)的基因组扩增:放射抗性的细胞机制及临床意义。
Cancer Lett. 2017 Feb 1;386:87-99. doi: 10.1016/j.canlet.2016.11.014. Epub 2016 Nov 17.
8
Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.印度患者头颈部鳞状细胞癌13号染色体长臂缺失图谱:与肿瘤预后的相关性
Int J Exp Pathol. 2006 Apr;87(2):151-61. doi: 10.1111/j.0959-9673.2006.00467.x.
9
Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者脱落细胞样本甲基化图谱的评估。
Head Neck. 2014 May;36(5):631-7. doi: 10.1002/hed.23345. Epub 2013 Jul 2.
10
Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.患者存在 Gorlin 综合征,因 9q22.3 微缺失导致包括 PTCH1 和 FANC-C 在内的多个肿瘤类型,包括平滑肌瘤和肾母细胞瘤。
Am J Med Genet A. 2013 Nov;161A(11):2894-901. doi: 10.1002/ajmg.a.36259. Epub 2013 Oct 7.

引用本文的文献

1
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.与口咽鳞状细胞癌中HPV整合引起的炎症反应相关的基因突变
Biomedicines. 2023 Dec 21;12(1):24. doi: 10.3390/biomedicines12010024.
2
MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma.MFI2上调通过表皮生长因子/黏着斑激酶信号通路促进口腔鳞状细胞癌的恶性进展。
Cancer Cell Int. 2023 Jun 12;23(1):112. doi: 10.1186/s12935-023-02956-0.
3
Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma.
PHF2表达在透明细胞肾细胞癌中的意义
J Pathol Transl Med. 2017 Jul;51(4):359-364. doi: 10.4132/jptm.2017.03.16. Epub 2017 Jun 13.
4
Fanconi anemia: young patients at high risk for squamous cell carcinoma.范科尼贫血:鳞状细胞癌的年轻高危患者。
Mol Cell Pediatr. 2014 Dec;1(1):9. doi: 10.1186/s40348-014-0009-8. Epub 2014 Nov 1.
5
Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival.范可尼贫血途径基因 BRCA2 和 FANCA 中的遗传变异可预测黑色素瘤的生存。
J Invest Dermatol. 2015 Feb;135(2):542-550. doi: 10.1038/jid.2014.416. Epub 2014 Sep 22.